Veru PE Ratio 2012-2025 | VERU
Current and historical p/e ratio for Veru (VERU) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veru PE ratio as of January 15, 2026 is 0.00.
| Veru PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-15 | 2.42 | 0.00 | |
| 2025-09-30 | 3.80 | $-1.60 | 0.00 |
| 2025-06-30 | 5.82 | $-2.20 | 0.00 |
| 2025-03-31 | 4.90 | $-2.40 | 0.00 |
| 2024-12-31 | 6.51 | $-2.60 | 0.00 |
| 2024-09-30 | 7.69 | $-2.80 | 0.00 |
| 2024-06-30 | 8.41 | $-4.80 | 0.00 |
| 2024-03-31 | 7.00 | $-3.40 | 0.00 |
| 2023-12-31 | 7.20 | $-7.50 | 0.00 |
| 2023-09-30 | 7.19 | $-11.30 | 0.00 |
| 2023-06-30 | 11.90 | $-13.80 | 0.00 |
| 2023-03-31 | 11.60 | $-17.30 | 0.00 |
| 2022-12-31 | 52.80 | $-14.30 | 0.00 |
| 2022-09-30 | 115.20 | $-10.50 | 0.00 |
| 2022-06-30 | 113.00 | $-5.90 | 0.00 |
| 2022-03-31 | 48.30 | $-3.40 | 0.00 |
| 2021-12-31 | 58.90 | $-2.00 | 0.00 |
| 2021-09-30 | 85.30 | $1.10 | 77.55 |
| 2021-06-30 | 80.70 | $-0.10 | 0.00 |
| 2021-03-31 | 107.75 | $-0.30 | 0.00 |
| 2020-12-31 | 86.50 | 0 | 0.00 |
| 2020-09-30 | 26.20 | $-2.80 | 0.00 |
| 2020-06-30 | 33.40 | $-1.60 | 0.00 |
| 2020-03-31 | 32.70 | $-1.50 | 0.00 |
| 2019-12-31 | 33.50 | $-2.00 | 0.00 |
| 2019-09-30 | 21.60 | $-1.80 | 0.00 |
| 2019-06-30 | 21.30 | $-2.70 | 0.00 |
| 2019-03-31 | 14.60 | $-3.80 | 0.00 |
| 2018-12-31 | 14.00 | $-3.90 | 0.00 |
| 2018-09-30 | 14.20 | $-4.40 | 0.00 |
| 2018-06-30 | 20.20 | $-4.00 | 0.00 |
| 2018-03-31 | 18.10 | $-2.80 | 0.00 |
| 2017-12-31 | 11.40 | $-2.70 | 0.00 |
| 2017-09-30 | 26.50 | $-2.30 | 0.00 |
| 2017-06-30 | 10.50 | $-1.90 | 0.00 |
| 2017-03-31 | 10.10 | $-1.40 | 0.00 |
| 2016-12-31 | 9.10 | $-0.80 | 0.00 |
| 2016-09-30 | 12.20 | $0.10 | 122.00 |
| 2016-06-30 | 12.60 | $0.90 | 14.00 |
| 2016-03-31 | 18.70 | $1.10 | 17.00 |
| 2015-12-31 | 14.50 | $1.70 | 8.53 |
| 2015-09-30 | 15.80 | $1.50 | 10.53 |
| 2015-06-30 | 18.00 | $1.10 | 16.36 |
| 2015-03-31 | 28.30 | $1.10 | 25.73 |
| 2014-12-31 | 39.20 | $0.60 | 65.33 |
| 2014-09-30 | 34.90 | $0.80 | 43.63 |
| 2014-06-30 | 55.10 | $3.30 | 16.70 |
| 2014-03-31 | 76.88 | $3.20 | 24.03 |
| 2013-12-31 | 84.14 | $4.30 | 19.57 |
| 2013-09-30 | 96.92 | $5.00 | 19.38 |
| 2013-06-30 | 96.84 | $5.60 | 17.29 |
| 2013-03-31 | 70.47 | $6.20 | 11.37 |
| 2012-12-31 | 69.33 | $5.70 | 12.16 |
| 2012-09-30 | 68.39 | $5.40 | 12.67 |
| 2012-06-30 | 55.58 | $4.10 | 13.56 |
| 2012-03-31 | 51.26 | $3.30 | 15.53 |
| 2011-12-31 | 42.25 | $2.60 | 16.25 |
| 2011-09-30 | 37.83 | $1.80 | 21.02 |
| 2011-06-30 | 45.86 | $2.10 | 21.84 |
| 2011-03-31 | 45.72 | $2.00 | 22.86 |
| 2010-12-31 | 52.09 | $2.60 | 20.03 |
| 2010-09-30 | 46.72 | $2.20 | 21.24 |
| 2010-06-30 | 47.04 | $1.10 | 42.76 |
| 2010-03-31 | 64.93 | $1.30 | 49.95 |
| 2009-12-31 | 42.80 | $1.40 | 30.57 |
| 2009-09-30 | 45.69 | $2.30 | 19.87 |
| 2009-06-30 | 43.43 | $2.30 | 18.88 |
| 2009-03-31 | 33.39 | $2.30 | 14.52 |
| 2008-12-31 | 32.12 | $2.00 | 16.06 |
| 2008-09-30 | 27.55 | $1.70 | 16.21 |
| 2008-06-30 | 23.98 | $1.30 | 18.44 |
| 2008-03-31 | 22.44 | $1.20 | 18.70 |
| 2007-12-31 | 23.62 | $0.90 | 26.24 |
| 2007-09-30 | 21.26 | $0.50 | 42.53 |
| 2007-06-30 | 19.63 | $0.10 | 196.34 |
| 2007-03-31 | 20.18 | 0 | 0.00 |
| 2006-12-31 | 13.93 | $-0.10 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.038B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| ICU Medical (ICUI) | United States | $3.666B | 23.28 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |